Papers
2
Total Citations
28
H-Index
2
About
Hualin Liao is a leading surgical oncologist whose research focuses on minimally invasive gastrointestinal cancer surgery, particularly robotic and laparoscopic approaches for gastric and rectal cancers. His major contributions center on comparing the surgical and oncological outcomes of robotic-assisted versus laparoscopic-assisted distal gastrectomy for advanced gastric cancer, a field where long-term data remain scarce. In a landmark 2022 study involving 1,164 patients, Liao demonstrated through propensity score-matched analysis that robotic-assisted distal gastrectomy with D2 lymphadenectomy offers comparable oncological safety to laparoscopic techniques, providing critical evidence for surgical decision-making. This work, cited 25 times, has helped establish robotic surgery as a viable option for advanced gastric cancer. More recently, Liao has explored quality-of-life outcomes, including a 2024 study on sexual function in early-onset overweight male rectal cancer patients following robotic surgery—an underexamined but clinically important topic. His research bridges technical surgical innovation with patient-centered outcomes, offering valuable insights for surgeons and oncologists seeking to optimize both survival and postoperative quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2